Please use this identifier to cite or link to this item: https://doi.org/10.1191/0961203303lu328oa
Title: High prevalence of antiphospholipid antibodies in Asian cancer patients with thrombosis
Authors: Yoon, K.H. 
Wong, A.
Shakespeare, T.
Sivalingam, P.
Keywords: Anti-beta-2 glycoprotein-I IgA
Antiphospholipid antibodies
Cancer
Thrombosis
Issue Date: 2003
Citation: Yoon, K.H., Wong, A., Shakespeare, T., Sivalingam, P. (2003). High prevalence of antiphospholipid antibodies in Asian cancer patients with thrombosis. Lupus 12 (2) : 112-116. ScholarBank@NUS Repository. https://doi.org/10.1191/0961203303lu328oa
Abstract: Thrombotic complications are a significant cause of morbidity and mortality in cancer patients. Studies in Caucasian populations have shown that up to one-third of such patients test positive to antiphospholipid antibodies. Our aim was to determine the prevalence and serotypes of antiphospholipid antibodies in an unselected group of Asian cancer patients with thrombosis. All patients with cancer-related thrombosis seen in the Department of Hematology-Oncology and Radiation Oncology were enrolled in this study. The study period was from April 2000 to May 2001. Antiphospholipid antibodies tests were performed, namely lupus anticoagulant screen, anticardiolipin antibodies (IgG and IgM) and anti-beta-2 glycoprotein I antibodies (B2 GPI) IgG, IgM and IgA. Thirty-three patients were recruited. There were 14 males and 19 females, with an age range of 35-78 years of age. Of those enrolled, there were 25 Chinese, five Malays and three Indians. The patients had several cancer types: 11 (36.7%) patients had adenocarcinoma as the histological cell type. Of the 33 patients, 75.8% had stage IV disease. Arterial thrombosis was seen in eight patients (24.2%), and venous thrombosis occurred in 29 patients (87.9%). Antiphospholipid antibodies were positive in 60.6% of the patients, of which anti-B2GPI IgA antibody was the most prevalent antiphospholipid present (46.9%). The presence of anti-beta-2 glycoprotein I IgA antibody was associated with strokes, extensive and recurrent venous thrombosis, and coincident arterial and venous thrombosis. A high prevalence of antiphospholipid antibodies (60.6%) was found in Asian patients with cancer-related thrombosis. The presence of antiphospholipid antibodies, particularly anti B2GPI IgA, may identify a subset of cancer patients who are at high risk of developing thrombotic complications, and further studies are warranted.
Source Title: Lupus
URI: http://scholarbank.nus.edu.sg/handle/10635/130913
ISSN: 09612033
DOI: 10.1191/0961203303lu328oa
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

44
checked on Sep 19, 2018

WEB OF SCIENCETM
Citations

42
checked on Sep 5, 2018

Page view(s)

10
checked on May 3, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.